Latest News & Features
Biotechnology
Illumina and Molecular Loop have filed complaints over DNA testing innovations | Illumina said one Molecular Loop patent was unenforceable due to ‘inequitable conduct’ 11 June 2024
Big Pharma
Victory for Amneal Pharmaceuticals as court dismisses infringement claims | Decision orders Teva to remove patents covering its breathing drug from the FDA's Orange Book | Paves the way for Amneal's generic version. 11 June 2024
Careers
Latest addition to the firm brings medtech expertise and experience assisting digital health companies using AI and machine learning | Move comes at a time when “health care companies are thinking more like technology companies”. 6 June 2024
Big Pharma
Swiss multinational claims Trividia infringed two patents | Roche says former employees with knowledge of patents joined Sinocare subsidiary. 6 June 2024
Biotechnology
Complaint sought judicial validation of the company's patent claims for a distributive shock treatment | Disputes the PTAB's decision deeming the invention obvious. 6 June 2024
article
Court seen as “exceeding expectations” | Experts urge caution, emphasising that confident and reliable court judgments are needed | High-stakes patent litigation, especially in pharmaceuticals, remains predominantly within national courts. 4 June 2024
Big Pharma
Delaware judge denies DexCom’s motion to dismiss two counter-counterclaims in complex dispute with rival Abbott over glucose monitors | But judge also says Abbott is not entitled to further remedy. 4 June 2024
Careers
ABG IP says the promotions recognise staff performance, improve gender equality and lower the average age among partners, and secure its values and position in the market. 4 June 2024
Medtech
University of British Columbia alleges patent infringement by medtech companies | Suit concerns AI-driven ultrasound systems for cardiac imaging. 30 May 2024
Americas
International Health Brands takes aim at former COO alleging trade secret theft of ingredients in immunity gummies | Accusations include deceptive marketing strategies, infringement, unfair competition, and misappropriation of trade secrets. 30 May 2024